In general, the instant invention comprises compounds having Formulae I
and II: ##STR00001## including pharmaceutically acceptable salts
thereof. The compounds of the invention are useful as protein kinase
inhibitors and therefore are useful for treating cancer and other protein
kinase mediated diseases.